Drugmakers Double Prices on Dozens of Treatments Since 2007

Drugmakers Double Prices on Dozens of Treatments Since 2007

Chris Ratcliffe/Bloomberg

A collection of a cell compound solution at Neusentis Ltd.'s research laboratory, a unit of Pfizer Inc., in Cambridge, U.K.